Blood Platelets Market – By Platelet Type (Apheresis Derived Platelets, Whole-blood Derived Platelets), Application (Thrombocytopenia, Hemato-oncology, Perioperative Indications, Hemophilia, Platelet Function Disorders), End Use & Forecast, 2024 – 2032

Blood Platelets Market Size

Blood Platelets Market size was valued at USD 5.6 billion in 2023 and is expected to exhibit growth at a CAGR of 4.2% from 2024 to 2032. The increasing prevalence of chronic and blood-related disorders coupled with growing demand for blood transfusions are significantly driving the market growth.
 

The growing incidence of chronic and blood-related disorders is a key factor driving the expansion of the market. Conditions such as cancer, cardiovascular diseases, and hemophilia frequently result in platelet deficiencies, fueling the need for platelet transfusions. Factors behind this trend include an aging population, lifestyle-related health issues, and increasing cancer rates. For instance, according to the World Health Organization, cardiovascular diseases are responsible for 17.9 million deaths annually, many involving platelet therapies. As the prevalence of these chronic and blood-related disorders continues to rise, the demand for blood platelets is expected to grow, further driving the market's expansion in the coming years.
 

Moreover, the growing demand for blood transfusions diagnostics, particularly in trauma cases and surgical procedures, is further propelling the need for blood platelets. This increasing reliance on platelet transfusions is expected to significantly contribute to the sustained growth of the blood platelets market.
 

Blood platelets are small, disc-shaped cell fragments in the blood that play a crucial role in hemostasis, the process of stopping bleeding. They are produced in the bone marrow from larger cells called megakaryocytes and lack a nucleus, making them unique among blood components.
 

Blood Platelets Market Trends

The rise in awareness regarding blood donations and platelet transfusions is emerging as a significant trend in the market.
 

• Campaigns and programs, such as World Blood Donor Day, have successfully highlighted the significance of blood and platelet donations. These initiatives are encouraging more voluntary donors, which in turn enhances the supply of platelets for critical medical treatments like surgeries and trauma care.
   
• Additionally, there is a growing emphasis on public education regarding the vital role of platelet transfusions in treating conditions such as cancer, organ transplants, and complex surgeries. This heightened awareness is driving an increased demand for platelets in healthcare settings.
   
• Furthermore, collaborations between healthcare institutions and blood banks are strengthening supply chains, ensuring that platelet transfusions are readily available to patients in need. These developments are contributing to both an increased supply and demand for platelets, thereby driving the overall growth of the market.
   

Blood Platelets Market Analysis

Based on platelet type, the market is classified into apheresis derived platelets and whole-blood derived platelet. The apheresis derived platelets segment generated the highest revenue of USD 3 billion in 2023.
 

• Apheresis technology allows for the collection of a larger number of platelets from a single donor compared to whole-blood donations. This efficiency is crucial for meeting the high demand for platelets, especially in critical medical situations such as surgeries and cancer treatments.
   
• Additionally, platelets collected via apheresis often have a longer shelf life compared to those obtained from whole blood, due to better preservation methods. This extended storage capability ensures a more reliable supply, contributing to the segment’s dominance in the market.
   

Based on application, the blood platelets market is categorized into thrombocytopenia, hemato-oncology, perioperative indications, hemophilia, platelet function disorders, and other applications. The thrombocytopenia segment dominated the market by obtaining 44.3% of market share in 2023.
 

• Thrombocytopenia characterized by a low platelet count is a common condition associated with various disorders, including autoimmune diseases, infections, and certain cancers. This high prevalence drives significant demand for platelet transfusions to manage and treat the condition.
   
• Patients with thrombocytopenia are at a higher risk of bleeding and require frequent platelet transfusions to prevent severe complications. This urgent need for treatment contributes to the dominance of this segment in the market.
   

Based on end-use, the blood platelets market is segmented into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment dominated the market in 2023 and is anticipated to reach USD 6.7 billion by 2032.
 

• Hospitals handle a large volume of patients requiring platelet transfusions, including those undergoing major surgeries, trauma care, and treatment for severe medical conditions like cancer. This high patient turnover significantly drives the demand for platelets.
   
• Additionally, hospitals provide a wide range of medical services that often necessitate platelet transfusions, such as emergency care, intensive care, and complex surgical procedures. The broad scope of treatments and procedures performed in hospitals increases their need for a steady supply of blood platelets.
   

North America blood platelets market accounted for USD 1.5 billion market revenue in 2023 and is anticipated to grow at CAGR of 2.8% between 2024 and 2032.
 

• North America has a significant incidence of blood disorders such as leukemia and lymphoma. The increasing number of cancer patients and those with blood disorders drives demand for blood platelets for treatments and research.
   
• Additionally, the region's advanced healthcare infrastructure, including state-of-the-art blood collection and processing facilities, enhances the efficiency and safety of platelet transfusions. This infrastructure supports high-quality blood platelet management and contributes to market growth.
   

U.S. blood platelets market accounted for USD 1.5 billion market revenue in 2023 and is estimated to hold substantial share between 2024 – 2032 period.
 

• The U.S. has extensive blood donation campaigns and programs organized by organizations like the American Red Cross. These initiatives help ensure a steady supply of platelets and meet the growing demand driven by medical conditions and emergencies.
   
• Moreover, significant investment in medical research and technology, particularly in areas related to hematology and blood management, supports the development of innovative platelet collection and processing techniques, contributing to market expansion.
   

UK blood platelets market is projected to grow remarkably in the coming years.
 

• The UK has seen an increase in the diagnosis of blood disorders such as anemia and thrombocytopenia, which drives the demand for platelet transfusions and enhances the growth of the market.
   
• Additionally, the UK government and the National Health Service (NHS) have initiatives to improve blood donation rates and platelet availability. These programs aim to boost donation levels and ensure the efficient management of blood products.
   

Japan holds a dominant position in the Asia Pacific blood platelets market.
 

• Japan's rapidly aging population leads to a higher prevalence of age-related blood disorders and conditions requiring platelet transfusions. This demographic shift drives the demand for blood platelets to support elderly care and chronic disease management.
   
• Additionally, Japan is known for its advancements in medical technology, including blood collection and processing systems. Innovative technologies and efficient blood management practices in Japan contribute to the growth and efficiency of the market.
   

Blood Platelets Market Share

The market is dominated by some of the major market players. The market is fragmented in nature, with major organizations, local small players, and start-ups joining the industry competition. The key industry players are consistently involved in creating new opportunities in the healthcare sector. Few of the players operating in the market include American National Red Cross, Canadian Blood Services, French Red Cross, Japanese Red Cross Society, and European Blood Alliance among others.
 

Blood Platelets Market Companies

Prominent players operating in the blood platelets industry include:

• American Association of Blood Banks (AABB)
• American National Red Cross
• America's Blood Centers
• Blood Centers of America
• Brazilian Red Cross
• Canada Blood Services
• French Red Cross
• German Red Cross
• Indian Red Cross Society
• Italian Red Cross
• Japanese Red Cross Society
• OneBlood
• Red Cross Society of China
• South African Red Cross
• Spanish Red Cross
• The European Blood Alliance (EBA)
   

Blood Platelets Industry News:

• In February 2022, the Association for the Advancement of Blood & Biotherapies launched the Alliance for a Strong Blood Supply, a coalition that comprises the AHA and other organizations committed to ensuring sufficient blood for patients during the pandemic and beyond. This coalition partners on advocacy & communications campaigns to drive blood donation and share best practices for blood supply stewardship. This may improve the organizations reputation in the market.
   
• In August 2022, America’s Blood Centers joined the worldwide campaign encouraging all eligible donors to give blood in a global attempt to break the world record for the most blood donations. This development helped the organization in boosting its brand visibility.
   

The blood platelets market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Platelet Type

• Apheresis derived platelets
• Whole-blood derived platelet

Market, By Application

• Thrombocytopenia
• Hemato-oncology
• Perioperative indications
• Hemophilia
• Platelet function disorders
• Other applications

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa